Corinne Le Goff
Chief Commercial OfficerViatris
PharmaceuticalsView Profile →Senior Vice President, Global Ophthalmology Commercial Business Unit · Regeneron Pharmaceuticals
Kevin Clark is senior vice president of the global ophthalmology commercial business unit at Regeneron Pharmaceuticals. He joined in 2019 after sixteen years at Novartis Pharmaceuticals. His responsibilities include commercial strategy, execution and development of the ophthalmology business team.
Last reviewed: Oct 21, 2026
Senior Vice President, Global Ophthalmology Commercial Business Unit Regeneron Pharmaceuticals
Last Reviewed: October 21, 2026
Kevin Clark is senior vice president of the global ophthalmology commercial business unit at Regeneron Pharmaceuticals. He joined in 2019 after sixteen years at Novartis Pharmaceuticals. His responsibilities include commercial strategy, execution and development of the ophthalmology business team.
Clark developed his pharmaceutical career at Novartis Pharmaceuticals, where he spent sixteen years in roles of increasing responsibility. Regeneron’s current biography does not specify the titles or dates of those individual assignments.
He joined Regeneron in 2019 and now serves as senior vice president of the Global Ophthalmology Commercial Business Unit. His team is responsible for the commercial strategy and execution supporting the company’s ophthalmology business, including recruiting and developing employees.
The position connects business planning with the organization delivering ophthalmology medicines to the market. It is a commercial leadership role rather than a clinical research or physician appointment. The reviewed primary biography does not date his promotion to senior vice president or identify individual launch outcomes attributable to him; neither is inferred. His documented career chain is Novartis followed by Regeneron.
Clark earned a BA from the University of Maryland. His field of study is not specified in the reviewed corporate biography.